Off the wire
• Israel demands France to renounce Orange's boycott comment  • Chinese FM urges bigger role for SCO in regional security  • Urgent: 20 army personnel killed in militant ambush in NE India  • Palestinian National Council urges world to end Israeli occupation  • Over 100 killed in fuel station explosion in Ghana's capital  • News Analysis: China stock market prepares for tide of foreign capital  • Ukraine to boost defense spending to deal with threats in east  • Hosts China continues medal rush, men's 100m AR smashed at Asian Championships  • About 1000 Syrian refugees enter Turkey in fresh exodus from Kurds-IS fighting  • German scientists find important mechanism of human hearing system  
You are here: 　 Home

Denmark's Novozymes to build new innovation center

Xinhua, June 4, 2015 Adjust font size:

Danish industrial enzyme maker Novozymes is to establish a new research center here, aimed at creating a global hub for biotech research and business development, the company announced Thursday.

The 140,000-square-meter site will be located in Lyngby, some 13 kilometers north of Copenhagen.

"This is an investment in the future, where the new innovation campus will be a cornerstone for our global research," said Per Falholt, executive vice president for R&D at Novozymes, in a statement.

"Novozymes is driven by innovation and this center will help strengthen our growth through developing ground-breaking biotechnology," he said.

The first building phase consists of a 30,000-square-meter construction, with room for 800 employees in research and development and other business areas.

Nozozymes estimates that the first phase can meet its space needs until the year 2023, noting that later expansion is possible to accommodate a total of 2,000 to 2,500 employees.

As part of the campus construction, Novozymes will also establish a learning center where students and visitors alike are invited to discover and learn about the biological knowledges, the company said.

The inauguration of the new innovation campus is expected to take place in 2018 upon the approval of the district plan.

Novozymes is a leading global enzyme manufacturer, with a global market share of 48 percent. Endit